Report Detail

Request for Sample of this report

Other Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3651294
    • |
  • 07 August, 2019
    • |
  • Global
    • |
  • 121 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

Scope of the Report:
The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Roche (including Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical Co

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others

Market Segment by Applications, can be divided into
Drug Store
Hospital Pharmacies
Online


Table of Contents

    1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview

    • 1.1 Product Overview and Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • 1.2 Classification of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Types
      • 1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Types in 2018
      • 1.2.3 Aspirin
      • 1.2.4 Ibuprofen
      • 1.2.5 Naproxen
      • 1.2.6 Celecoxib
      • 1.2.7 Others
    • 1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application
      • 1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Drug Store
      • 1.3.3 Hospital Pharmacies
      • 1.3.4 Online
    • 1.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Regions
      • 1.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Roche (including Genentech)
      • 2.1.1 Business Overview
      • 2.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Roche (including Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Amgen
      • 2.2.1 Business Overview
      • 2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 B-MS
      • 2.3.1 Business Overview
      • 2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Merck
      • 2.4.1 Business Overview
      • 2.4.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pfizer
      • 2.5.1 Business Overview
      • 2.5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Novartis
      • 2.6.1 Business Overview
      • 2.6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Eli Lilly and Company
      • 2.7.1 Business Overview
      • 2.7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Johnson & Johnson
      • 2.8.1 Business Overview
      • 2.8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 GSK
      • 2.9.1 Business Overview
      • 2.9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Sanofi
      • 2.10.1 Business Overview
      • 2.10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Boehringer Ingelheim
      • 2.11.1 Business Overview
      • 2.11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Zhejiang Jiuzhou Pharmaceutical Co
      • 2.12.1 Business Overview
      • 2.12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Zhejiang Jiuzhou Pharmaceutical Co Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competition, by Players

    • 3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
      • 3.2.2 Top 10 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
    • 3.3 Market Competition Trend

    4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions

    • 4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Regions
    • 4.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 4.5 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)

    5 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries

    • 5.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
    • 5.2 USA Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)

    6 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries

    • 6.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
    • 6.2 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 6.3 UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 6.4 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries

    • 7.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
    • 7.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 7.5 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)

    8 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries

    • 8.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
    • 8.2 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Countries

    • 9.1 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2014-2019)

    10 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Type

    • 10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2019-2024)
    • 10.3 Aspirin Revenue Growth Rate (2014-2024)
    • 10.4 Ibuprofen Revenue Growth Rate (2014-2024)
    • 10.5 Naproxen Revenue Growth Rate (2014-2024)
    • 10.6 Celecoxib Revenue Growth Rate (2014-2024)
    • 10.7 Others Revenue Growth Rate (2014-2024)

    11 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Application

    • 11.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2014-2019)
    • 11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2019-2024)
    • 11.3 Drug Store Revenue Growth (2014-2019)
    • 11.4 Hospital Pharmacies Revenue Growth (2014-2019)
    • 11.5 Online Revenue Growth (2014-2019)

    12 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2019-2024)

    • 12.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2019-2024)
    • 12.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Regions (2019-2024)
    • 12.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
    • 12.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
    • 12.6 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) . Industry analysis & Market Report on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is a syndicated market report, published as Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,246.84
      		4,870.26
      		6,493.68
      		543,784.80
      		815,677.20
      		1,087,569.60
      		290,475.60
      		435,713.40
      		580,951.20
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo